Time course of lymphocyte repopulation after dimethyl fumarate-induced grade 3 lymphopenia: contribution of patient age

BACKGROUND: Dimethyl fumarate (DMF) is licensed for treatment of relapsing–remitting multiple sclerosis (RRMS). DMF can induce lymphopenia, which is assumed to increase the risk for opportunistic infections like progressive multifocal leukoencephalopathy. Our goal for this work was to estimate the f...

Descripción completa

Detalles Bibliográficos
Autores principales: Briner, Myriam, Bagnoud, Maud, Miclea, Andrei, Friedli, Christoph, Diem, Lara, Chan, Andrew, Hoepner, Robert, Salmen, Anke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506915/
https://www.ncbi.nlm.nih.gov/pubmed/31105768
http://dx.doi.org/10.1177/1756286419843450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506915/
https://www.ncbi.nlm.nih.gov/pubmed/31105768
http://dx.doi.org/10.1177/1756286419843450

Ejemplares similares